Taobao Maker Festival Supercharges China Creativity And Design


Twenty of China's top independent designers featured their newest collections in a supercharged fashion show at this year's Taobao Maker Festival.
   
The show, using West Lake's Broken Bridge as a catwalk for models, was a festival of creativity and design. Also, a revelation of innovative technology harnessing Alibaba's effective 'See Now, Buy Now' format. It highlighted collections offering a chic modern flourish on classic Chinese culture and was a live broadcast on Youku and Taobao. 
   
Created for the Taobao Maker Festival, the collections were fresh statements from young designers exploring a reinterpretation of Chinese culture. The collections showed appreciation of Chinese heritage, with traditional art motifs and symbols sampled in the compositions. They also displayed vibrant modish tweaks tailored to the tastes of Chinese millennials.
   
Among the twenty designers, Liu Qingyang, acclaimed for her prints, animated definitive Chinese elements with an artistic aesthetic. Li Kun, champion of reality show 'Fashion Master', culled attributes of Chinese history and culture, offering them in a cleverly minimal mode. Muzkin's assemblage centered on a fictional character, Nezha, bringing the traditional Chinese protection deity to life.
   
These collections will continue to be available on the Taobao platform.  Original designs enjoy a 4.3 times price premium over mass productions, and the customer base for designer items is expanding.  In the fourth quarter of 2017 alone, 'original design' appeared 170 million times in keyword searches on Taobao.

Comments

Post a Comment

Popular posts from this blog

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy ...
Read more

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. T...
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address ...
Read more